Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gibbs

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Surgical Orthopaedic Advances|April 1, 2020
Opioid Prescribing and Patient Satisfaction Scores Across Practice TypesEric Secrist, Meghan K Wally, Richard McKnight, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agentsMichael P Deninno, Melissa Andrews, Andrew S Bell, et al.
Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Bioorganic & Medicinal Chemistry|July 23, 2013
Defining the key pharmacophore elements of PF-04620110: discovery of a potent, orally-active, neutral DGAT-1 inhibitorRobert L Dow, Melissa P Andrews, Jian-Cheng Li, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2013
Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humansBenjamin S Maciejewski, Jennifer L LaPerle, Danny Chen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 13, 2020
Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavitiesPaul R Stauffer, Dario B Rodrigues, Robert Goldstein, et al.
Chemistry & Biology|September 3, 2002
Structure-activity analysis of the purine binding site of human liver glycogen phosphorylaseJennifer L Ekstrom, Thomas A Pauly, Maynard D Carty, et al.
Geriatric Orthopaedic Surgery & Rehabilitation|October 17, 2022
Balancing Safety, Comfort, and Fall Risk: An Intervention to Limit Opioid and Benzodiazepine Prescriptions for Geriatric PatientsAinsley Bloomer, Meghan Wally, Gisele Bailey, et al.
Plos One|November 11, 2011
Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platformAhmed E Enayetallah, Daniel Ziemek, Michael T Leininger, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterizationStephen W Wright, Virginia L Rath, Paul E Genereux, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Surgical Orthopaedic Advances|April 1, 2020
Opioid Prescribing and Patient Satisfaction Scores Across Practice TypesEric Secrist, Meghan K Wally, Richard McKnight, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agentsMichael P Deninno, Melissa Andrews, Andrew S Bell, et al.
Clinical Pharmacology and Therapeutics|July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 InfectionRachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Bioorganic & Medicinal Chemistry|July 23, 2013
Defining the key pharmacophore elements of PF-04620110: discovery of a potent, orally-active, neutral DGAT-1 inhibitorRobert L Dow, Melissa P Andrews, Jian-Cheng Li, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2013
Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humansBenjamin S Maciejewski, Jennifer L LaPerle, Danny Chen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|October 13, 2020
Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavitiesPaul R Stauffer, Dario B Rodrigues, Robert Goldstein, et al.
Chemistry & Biology|September 3, 2002
Structure-activity analysis of the purine binding site of human liver glycogen phosphorylaseJennifer L Ekstrom, Thomas A Pauly, Maynard D Carty, et al.
Geriatric Orthopaedic Surgery & Rehabilitation|October 17, 2022
Balancing Safety, Comfort, and Fall Risk: An Intervention to Limit Opioid and Benzodiazepine Prescriptions for Geriatric PatientsAinsley Bloomer, Meghan Wally, Gisele Bailey, et al.
Plos One|November 11, 2011
Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platformAhmed E Enayetallah, Daniel Ziemek, Michael T Leininger, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterizationStephen W Wright, Virginia L Rath, Paul E Genereux, et al.
Pageof 8